Macquarie Group LTD Ocugen, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.5 - $1.83 $2,941 - $10,765	5,883 New	5,883 $9,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $4,858 - $8,605	-2,776 Reduced 28.79%	6,866 $17,000
Q4 2021 Feb 11, 2022	BUY	$4.38 - $15.67 $12,158 - $43,499	2,776 Added 40.43%	9,642 $44,000
Q2 2021 Aug 13, 2021	BUY	$5.52 - $15.68 $37,900 - $107,658	6,866 New	6,866 $55,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.